{"results": [{"id": "0001583107:2014:FY", "start_date": "2014-01-01", "end_date": "2014-12-31", "filing_date": "2015-03-13", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2014", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001047469-15-002175", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001047469-15-002175/files/tbph-20141231.xml", "financials": {"income_statement": {"income_loss_before_equity_method_investments": {"value": -230674000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_tax_expense_benefit": {"value": 6364000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -237038000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit_current": {"value": 6364000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "income_loss_from_continuing_operations_before_tax": {"value": -230674000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "cost_of_revenue_goods": {"value": 4058000.0, "unit": "USD", "label": "Cost Of Revenue, Goods", "order": 400}, "net_income_loss": {"value": -237038000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 242362000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "revenues": {"value": 11688000.0, "unit": "USD", "label": "Revenues", "order": 100}, "gross_profit": {"value": 7630000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "operating_expenses": {"value": 244227000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -237038000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -232539000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit_deferred": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 242362000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -237038000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "cost_of_revenue": {"value": 4058000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}}, "balance_sheet": {"equity_attributable_to_parent": {"value": 289787000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 6728000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 337771000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 337771000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 275370000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_than_fixed_noncurrent_assets": {"value": 52738000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "fixed_assets": {"value": 9663000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities": {"value": 47984000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 289787000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 41256000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 62401000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -106251000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 89215000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 89215000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 370621000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -175155000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 370621000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -106251000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -175155000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -237211000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -237211000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -237211000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"id": "0001583107:2015:FY", "start_date": "2015-01-01", "end_date": "2015-12-31", "filing_date": "2016-03-11", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2015", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001047469-16-011039", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001047469-16-011039/files/tbph-20151231.xml", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": 23492000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 23492000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 81310000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 111039000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 81310000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 111039000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -168857000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -168857000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -182207000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -182207000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -182207000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"cost_of_revenue": {"value": 4657000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "operating_expenses": {"value": 224025000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -181899000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit": {"value": 951000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 42126000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -182219000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -182219000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "gross_profit": {"value": 37469000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_tax_expense_benefit_current": {"value": 951000, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "net_income_loss": {"value": -182219000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -181268000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "costs_and_expenses": {"value": 223394000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_tax_expense_benefit_deferred": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "income_loss_from_continuing_operations_after_tax": {"value": -182219000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 223394000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "cost_of_revenue_goods": {"value": 4657000.0, "unit": "USD", "label": "Cost Of Revenue, Goods", "order": 400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "balance_sheet": {"current_assets": {"value": 237472000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 243065000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 243065000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 7581000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 9873000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities_and_equity": {"value": 300116000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 49470000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_than_fixed_noncurrent_assets": {"value": 52771000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "noncurrent_assets": {"value": 62644000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 57051000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 300116000.0, "unit": "USD", "label": "Assets", "order": 100}}}}, {"id": "0001583107:2016:FY", "start_date": "2016-01-01", "end_date": "2016-12-31", "filing_date": "2017-03-01", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2016", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001047469-17-001086", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001047469-17-001086/files/tbph-20161231.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -190852000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -190852000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -190852000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"fixed_assets": {"value": 8460000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "assets": {"value": 639254000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 49268000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 239755000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 528503000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 639254000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 350231000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 110751000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_than_fixed_noncurrent_assets": {"value": 102291000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "liabilities": {"value": 289023000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 350231000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "income_statement": {"income_tax_expense_benefit_deferred": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "revenues": {"value": 48648000.0, "unit": "USD", "label": "Revenues", "order": 100}, "cost_of_revenue_goods": {"value": 2894000.0, "unit": "USD", "label": "Cost Of Revenue, Goods", "order": 400}, "income_loss_from_continuing_operations_after_tax": {"value": -190669000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -190669000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -180559000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -190669000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit_current": {"value": 10110000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 229115000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_tax_expense_benefit": {"value": 10110000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "gross_profit": {"value": 45754000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss_attributable_to_parent": {"value": -190669000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "costs_and_expenses": {"value": 229207000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 229207000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "cost_of_revenue": {"value": 2894000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "interest_expense_operating": {"value": 1404000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "operating_income_loss": {"value": -180467000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -98989000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -148235000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 232002000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -98989000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -148235000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 232002000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 479226000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 479226000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}, {"id": "0001583107:2017:FY", "start_date": "2017-01-01", "end_date": "2017-12-31", "filing_date": "2018-02-28", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2017", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001047469-18-001160", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001047469-18-001160/files/tbph-20171231.xml", "financials": {"balance_sheet": {"assets": {"value": 441400000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 62651000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 263670000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 10157000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities_and_equity": {"value": 441400000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 326222000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 115178000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 115178000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 378749000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 62552000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_than_fixed_noncurrent_assets": {"value": 52494000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -285885000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -285885000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -285885000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"costs_and_expenses": {"value": 287097000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_tax_expense_benefit_current": {"value": 13694000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "income_loss_from_continuing_operations_before_tax": {"value": -271711000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -285405000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -260123000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "gross_profit": {"value": 9356000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_tax_expense_benefit": {"value": 13694000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -285405000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit_deferred": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "cost_of_revenue": {"value": 6030000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -285405000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -285405000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "cost_of_revenue_goods": {"value": 6030000.0, "unit": "USD", "label": "Cost Of Revenue, Goods", "order": 400}, "benefits_costs_expenses": {"value": 287097000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "interest_expense_operating": {"value": 8547000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "revenues": {"value": 15386000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 275509000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 1656000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -255729000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -56333000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -201052000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 1656000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -56333000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -201052000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -255729000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"id": "0001583107:2018:FY", "start_date": "2018-01-01", "end_date": "2018-12-31", "filing_date": "2019-02-28", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2018", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-19-001346", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-19-001346/files/tbph-20181231.xml", "financials": {"balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 560235000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 560235000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 532823000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_than_fixed_noncurrent_assets": {"value": 14236000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_parent": {"value": -51589000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 513270000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 27412000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 13176000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity": {"value": -51589000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 98554000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 611824000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "cash_flow_statement": {"net_cash_flow": {"value": 289041000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 289041000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 225200000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 176708000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -112867000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 176708000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -112867000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 225200000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -214957000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -214957000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -214957000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"costs_and_expenses": {"value": 286455000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_tax_expense_benefit": {"value": -10561000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_before_equity_method_investments": {"value": -237267000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_loss_from_continuing_operations_after_tax": {"value": -215524000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_tax_expense_benefit_current": {"value": -10561000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "revenues": {"value": 60370000.0, "unit": "USD", "label": "Revenues", "order": 100}, "interest_expense_operating": {"value": 10482000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_loss_from_continuing_operations_before_tax": {"value": -226085000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_equity_method_investments": {"value": 11182000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 299121000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -215524000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "benefits_costs_expenses": {"value": 286455000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -238751000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -215524000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -215524000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}}}, {"id": "0001583107:2019:FY", "start_date": "2019-01-01", "end_date": "2019-12-31", "filing_date": "2020-02-27", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2019", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-20-001644", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-20-001644/files/tbph-20191231x10kc43919_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": -236144000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -236144000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -236144000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 1291000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -238197000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 1291000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -238197000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -83051000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -319957000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -319957000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -83051000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "income_statement": {"operating_income_loss": {"value": -251915000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "interest_expense_operating": {"value": 31862000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_equity_method_investments": {"value": 33705000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "income_loss_before_equity_method_investments": {"value": -275382000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -236455000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit": {"value": -5222000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_tax_expense_benefit_current": {"value": -5222000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "benefits_costs_expenses": {"value": 315091000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": -241677000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 73414000.0, "unit": "USD", "label": "Revenues", "order": 100}, "costs_and_expenses": {"value": 315091000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -236455000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -236455000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -236455000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 325329000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "balance_sheet": {"noncurrent_liabilities": {"value": 520963000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": -223840000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_than_fixed_noncurrent_assets": {"value": 57694000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 338488000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 111703000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 632666000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 70338000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": -223840000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 408826000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 408826000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 12644000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}}}}, {"id": "0001583107:2020:FY", "start_date": "2020-01-01", "end_date": "2020-12-31", "filing_date": "2021-02-26", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2020", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-21-002006", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-21-002006/files/tbph-20201231x10k_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -278115000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -278115000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -278115000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"noncurrent_liabilities": {"value": 649237000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 469057000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 75716000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 393341000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 469057000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 123571000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": -303751000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_than_fixed_noncurrent_assets": {"value": 59294000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "fixed_assets": {"value": 16422000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity_attributable_to_parent": {"value": -303751000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 772808000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -286537000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -278017000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_equity_method_investments": {"value": 68438000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "costs_and_expenses": {"value": 358394000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -278017000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 369614000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 71857000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_tax_expense_benefit_current": {"value": -8520000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 358394000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "interest_expense_operating": {"value": 44585000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_before_equity_method_investments": {"value": -354975000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_loss_from_continuing_operations_after_tax": {"value": -278017000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -278017000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -297757000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit": {"value": -8520000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 10721000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 23403000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 23403000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 263085000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 263085000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 10721000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -250403000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -250403000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}}}, {"id": "0001583107:2021:FY", "start_date": "2021-01-01", "end_date": "2021-12-31", "filing_date": "2022-02-28", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2021", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-22-002373", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-22-002373/files/tbph-20211231x10k_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 124494000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 8496000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 124494000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 91860000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -207858000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 8496000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 91860000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -207858000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"income_tax_expense_benefit_current": {"value": -151000, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "diluted_earnings_per_share": {"value": -2.87, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": -2.87, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": -199577000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_before_equity_method_investments": {"value": -303564000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_tax_expense_benefit": {"value": -151000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "benefits_costs_expenses": {"value": 254888000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_parent": {"value": -199426000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 313095000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "costs_and_expenses": {"value": 254888000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_expense_operating": {"value": 46889000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -257784000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -199426000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -199426000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_equity_method_investments": {"value": 103987000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "net_income_loss": {"value": -199426000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 55311000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "balance_sheet": {"other_than_fixed_noncurrent_assets": {"value": 111292000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "noncurrent_liabilities": {"value": 654805000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 13657000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities_and_equity": {"value": 374819000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 374819000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": -338573000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 713392000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 58587000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": -338573000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 249870000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 124949000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -199473000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -199473000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -199473000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}], "status": "OK", "request_id": "ab0aa4ca36bc0885eab7a666c79e4c01"}